Author

Zuzana Zemanová

Charles UniversityORCID 0000-0002-7538-6601Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

Adéla BerkováiD· 1 shared Alexandra DolníkováiD· 1 shared Anežka Rajmonová· 1 shared Dana SoviljiD· 1 shared Jana SeňavováiD· 1 shared Karla SvobodováiD· 1 shared Kristýna KupcováiD· 1 shared Ladislav AnděraiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adéla BerkováORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies

Nardjas Bettazová, Jana Seňavová, Kristýna Kupcová, Dana Sovilj, Anežka Rajmonová, Ladislav Anděra, Karla Svobodová, Adéla Berková, Vaclav Herman, Zuzana Zemanová, Lenka Daumová, Alexandra Dolníková, Richard Eric Davis, Marek Trněný, Pavel Klener, Ondřej Havránek

This study investigates how PIK3CA gain and PTEN loss affect MCL biology and drug response, finding reduced BCR dependence and increased therapy resistance.

Blood Advances · Aug 19, 2024Peer-reviewedCancer Biology